Researchers have uncovered an ancient genetic change that may help explain how Mycobacterium tuberculosis evolved to evade the immune system, persist in the body and reactivate years later.
https://t.co/BljU3Xr7uO
Are COVID-19 antivirals still an effective treatment option in 2026?
Clinical researchers share their perspective after reviewing large clinical trials in contemporary populations with more immunity.
https://t.co/GrYfjKPuhk
New research reveals B cells do much more than produce antibodies - they also help activate and sustain T cells to fight chronic infections, like cancer or auto immune diseases.
https://t.co/7wnvKSWjz7
A new study shows vaccination boosts immune responses, increasing B cells and antibodies, regardless of chronic health conditions. Findings help close a key gap in understanding vaccine responses in First Nations people.
https://t.co/hBUJsZGUS6
Next-generation flu vaccine delivers a stronger immune response to the A(H3N2) influenza strain in a new clinical trial, outperforming traditional egg- and cell-grown vaccines and highlighting the potential for improved seasonal protection.
https://t.co/JnYGJPKxGw
On Saturday the first case of high pathogenicity avian influenza (HPAI) H5N1 was confirmed in Australia. What does this mean for our wildlife population? Origin, transmission and prevention measures explained by experts.
https://t.co/aVl0b8C2Jn
@DuckSwabber
Most people labelled “penicillin allergic” aren’t allergic. This World Allergy Week, Melb led trial highlights new model to safely rule it out through bedside testing in hospitals. ✅ Faster decisions
✅ Right antibiotics
✅ Better patient outcomes
https://t.co/b3HZUvNHXf
🌍 Stories from the field | Nauru
A GOARN deployment with @WHO & @TheDohertyInst supported a scoping mission to strengthen Nauru’s public health laboratory systems and lay the groundwork for the country’s first national lab
https://t.co/0pTcdRXlXm
A landmark international clinical trial (SNAP Trial) has identified the optimal antibiotics for golden staph bloodstream infections, a breakthrough that is set to reshape treatment for the life-threatening condition.
https://t.co/G7PPVfWtbI
Discover our 2025 Impact Report, highlighting key achievements across the Doherty Institute's work in research, public health and education
Explore our digital 2025 Impact Report 🔗 https://t.co/We1flbmI6w
Parts of Australia are currently experiencing outbreaks of diphtheria, a vaccine-preventable bacterial illness. What causes diphtheria? What are the symptoms? How does it spread? Get answers to some of the most common questions about diphtheria.
https://t.co/XMPMhqpMPO
We launched a massive genetic "treasure hunt" for genes associated with TB, one of the world's leading infectious disease killers. To find out more see our paper just published in Genome Medicine!
@TheDohertyInst#EndTB
https://t.co/bkGLZDD73H
A current Ebola virus disease outbreak overseas has been declared a public health emergency of international concern by the WHO. Doherty Institute scientists unpack the key facts, from transmission and symptoms to laboratory testing and Australia’s risk.
https://t.co/aVdpY6lH9Z
Congratulations Prof Laura Mackay and Prof Katherine Kedzierska, two newly elected Fellows to the @Science_Academy in recognition of their contributions to immunology and infectious diseases research.
Learn more 🔗 https://t.co/ugSMpag7pY
@kedzierskalab@LMackayLab
Hantavirus has been in the news overseas, but what does it mean for Australia? Scientists at the Doherty Institute explain how the virus spreads, the symptoms it can cause, how testing works in Australia, and why the risk remains low.
https://t.co/RIaugEIc7E
Today is Day of Immunology, recognising immunologists and their impact on modern medicine. By deepening our understanding of how the immune system responds to disease, immunology helps inform advances such as vaccine development.